Novartis | Devedores Comerciais





Devedores Comerciais Alterar Data
AbbVie USD 12.77B 132M 2025-09
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bausch Health Companies USD 2.42B 207M 2025-09
Biogen USD 1.85B 234M 2025-09
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Canopy Growth CAD 26.86M 23.17M 2025-09
Corcept Therapeutics USD 69.63M 5.06M 2025-09
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Glaxosmithkline GBP 11.16B 3.46B 2025-09
J&J USD 17.61B 235M 2025-09
Merck USD 12.12B 596M 2025-09
Novartis USD 8.98B 192M 2025-09
Novartis USD 8.98B 192M 2025-09
Pacira USD 115.27M 901K 2025-09
Perrigo USD 644.4M 62.2M 2025-09
Pfizer USD 18.12B 2.02B 2025-09
Phibro Animal Health USD 160.78M 8.67M 2024-09
Prestige Brands USD 190.46M 8.54M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 397M 100M 2025-12
Sanofi EUR 397M 186.13M 2025-12
Supernus Pharmaceuticals USD 171.25M 30.42M 2025-09
Zoetis USD 1.59B 49M 2025-12


Novartis Devedores Comerciais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.